BriaCell Therapeutics (BCTX) News Today → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free BCTX Stock Alerts $2.14 -0.02 (-0.93%) (As of 04/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineQ3 2024 EPS Estimates for BriaCell Therapeutics Corp. (NASDAQ:BCTX) Lowered by HC Wainwrightamericanbankingnews.com - April 13 at 2:02 AMBriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancerglobenewswire.com - April 10 at 8:00 AMBriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACRfinance.yahoo.com - April 9 at 9:26 AMBriaCell Therapeutics Corp. (BCTX)sg.finance.yahoo.com - March 20 at 7:20 AMBriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapiesglobenewswire.com - March 7 at 8:00 AMBriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conferenceglobenewswire.com - March 6 at 8:00 AMBriaCell Provides Update on Alleged Illegal Trading of Public Securitiesfinance.yahoo.com - February 27 at 9:17 AMBriaCell Provides Update on Alleged Illegal Trading of Public Securitiesglobenewswire.com - February 27 at 8:00 AMBriaCell Therapeutics Corp. (BCTX) stock forecast and price targetfinance.yahoo.com - February 14 at 6:06 PMBriaCell Therapeutics (NASDAQ:BCTX) Trading 5.3% Higher marketbeat.com - February 7 at 4:49 AMBriaCell Therapeutics Corp. Announces Results of Shareholder Meetingfinance.yahoo.com - January 30 at 11:02 PMBriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patientsfinance.yahoo.com - December 28 at 9:18 AMBriaCell Therapeutics Stock (NASDAQ:BCTX) Dividends: History, Yield and Datesbenzinga.com - December 27 at 8:28 AMBriaCell Therapeutics' Cancer Drug Shows Preliminary Survival, Clinical Benefit In Pretreated Patientsmsn.com - December 20 at 2:15 PMBriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subsetfinance.yahoo.com - December 20 at 9:15 AMBriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCSfinance.yahoo.com - December 6 at 12:54 PMBCTX: November 2023 SITC Posterfinance.yahoo.com - November 8 at 3:16 PMBriaCell Therapeutics Corp Ordinary Shares - New BCTXmorningstar.com - November 4 at 5:42 PMBCTX: Year in Reviewfinance.yahoo.com - November 1 at 3:55 PMBriaCell Therapeutics Corp Ordinary Shares - Newmorningstar.com - October 24 at 2:15 AMBriaCell To Host Virtual Key Opinion Leader Event on Bria-IMT™ Potential in Advanced Metastatic Breast Cancer on October 26, 2023 Featuring Dr. Adam M. Brufsky from University of Pittsburgh School of Medicine and Dr. Saranya Chumsri from Mayo Clinicfinance.yahoo.com - October 11 at 12:31 PMBriaCell Therapeutics Corp. Announces Closing of Plan of Arrangement Spinning Out BriaPro Therapeutics Corp. to Existing Shareholdersfinance.yahoo.com - August 31 at 4:41 PMBriaCell Accepts Letter of Intent from Weill Cornell Medicine Outlining Plans to Initiate a Clinical Trial of Bria-IMT™ in High-Risk Early-Stage Triple Negative Breast Cancerfinance.yahoo.com - August 31 at 9:47 AMBriaCell receives court approval to launch spinoff aimed at accelerating cancer drug developmentbizjournals.com - August 28 at 1:29 PMBCTX: Pivotal Study Protocol Clearedfinance.yahoo.com - July 10 at 12:16 PMK.J. Harrison & Partners Inc Lowers Position in BriaCell Therapeutics Corp. (NASDAQ:BCTX)marketbeat.com - July 9 at 7:39 AMHC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $25 Price Targetbenzinga.com - June 28 at 9:50 AMFive Top Companies Fighting for the Treatment of Metastatic Breast Cancerbaystreet.ca - June 27 at 6:23 PMFDA Approves BriaCell’s Pivotal Registrational Study Design in Advanced Metastatic Breast Cancerfinance.yahoo.com - June 27 at 8:23 AMThere are Positive Developments in the Treatment of Metastatic Breast Cancerbaystreet.ca - May 25 at 10:09 AMFive Impressive Metastatic Cancer Treatment Stocks to Own Todaybaystreet.ca - May 15 at 1:48 PMBriaCell Announces $4 Million Strategic Investment and Clinical Alliance with Prevail Partners, LLC and Prevail InfoWorks, Inc.finance.yahoo.com - May 15 at 8:48 AMFY2023 EPS Estimates for BriaCell Therapeutics Corp. (NASDAQ:BCTX) Lowered by Analystmarketbeat.com - May 1 at 3:35 AMBCTX: Posters Galore at AACRfinance.yahoo.com - April 27 at 10:27 AMBriaCell Therapeutics (TSE:BCT) Is In A Good Position To Deliver On Growth Plansfinance.yahoo.com - April 10 at 8:06 AMShort Interest in BriaCell Therapeutics Corp. (NASDAQ:BCTX) Drops By 6.3%marketbeat.com - April 3 at 5:35 AMBriaCell plans spin-out of some pre-clinical assets into new entityseekingalpha.com - March 30 at 1:12 PMUSA News Group: Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancerfinanznachrichten.de - March 24 at 9:20 AMA BriaCell Therapeutics Corp. (TSE:BCT) insider increased their holdings by 20% last yearfinance.yahoo.com - March 14 at 8:25 AMBCTX: 82% Survival Benefitfinance.yahoo.com - March 9 at 10:47 AMBCTX BriaCell Therapeutics Corp.seekingalpha.com - February 28 at 6:28 AMBriaCell Therapeutics (NASDAQ:BCTX) Receives Buy Rating from HC Wainwrightmarketbeat.com - February 24 at 12:36 PMBriaCell Therapeutics Corp. (NASDAQ:BCTX) Shares Bought by Virtu Financial LLCmarketbeat.com - February 7 at 5:52 AMBriaCell Therapeutics Corp. (NASDAQ:BCTX) Short Interest Down 5.7% in Decembermarketbeat.com - January 23 at 3:10 AMLab Notes: Amicus founder gets national honor; Capstan and Code Bio land on list of companies to watchfinance.yahoo.com - January 20 at 1:32 PMBCTX: Down in San Antonefinance.yahoo.com - December 19 at 12:38 PMBriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patientsbenzinga.com - December 1 at 2:35 PMBriaCell Reports Positive Breast Cancer Efficacy Data with Bria-IMT™ Immunotherapy Treatment at SITC Annual Meetingfinance.yahoo.com - November 10 at 4:18 PMBCTX: Fiscal Year 2022 Resultsfinance.yahoo.com - October 31 at 12:59 PMBriaCell Therapeutics Corp. (NASDAQ:BCTX) Short Interest Down 16.9% in Septembermarketbeat.com - October 15 at 8:40 AM Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New crypto project uncovers 2,050% in 65 days (Ad)During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024. Just click here to sign up and be among the first to get it. BCTX Media Mentions By Week BCTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCTX News Sentiment▼-0.840.53▲Average Medical News Sentiment BCTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCTX Articles This Week▼40▲BCTX Articles Average Week Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CARA News UNCY News XLO News OCUP News PMN News DARE News RMTI News CALC News BOLT News CASI News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BCTX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceUrgent alert: open this for a huge profit potentialTimothy SykesHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.